PMID: 9430048Jan 16, 1998Paper

The international consensus process on psychopharmacology and intellectual disability

Journal of Intellectual Disability Research : JIDR
S Reiss, M G Aman

Abstract

The present authors invited 115 scientists, practitioners and consumers from 11 nations to form an international consensus panel on best practices and clinical effects regarding psychoactive medicines and intellectual disability. Co-sponsors included the American Association on Mental Retardation, the American Psychiatric Association, the American Psychological Association, the National Institute of Mental Health, the National Association on Dual Diagnosis and The Arc of the United States. The panel developed 21 reports that were revised to reflect comments from 351 participants at a 1995 Ohio State University conference in Columbus, OH, USA. The reports will be published as chapters in a forthcoming book entitled Psychotropic Medication and Developmental Disabilities: The International Consensus Handbook. The need for research and training programmes is discussed.

References

Mar 1, 1978·Journal of Neurology, Neurosurgery, and Psychiatry·M IivanainenE P Helle
Mar 1, 1991·Journal of the American Academy of Child and Adolescent Psychiatry·B L HandenS McAuliffe
Jun 1, 1989·Journal of Clinical Psychopharmacology·K D MeiselasM Campbell
Jul 1, 1989·Journal of the American Academy of Child and Adolescent Psychiatry·M G Aman, R A Kern
Jan 1, 1989·Research in Developmental Disabilities·E Zigler, J A Burack
Jan 1, 1986·Psychopharmacology·T J Feuerstein, R Jackisch
Jul 1, 1974·American Journal of Diseases of Children·J M VallartaA Reichert
Dec 1, 1969·Archives of Neurology·W J Logan, J M Freeman
Dec 1, 1994·Pediatrics in Review·F B Palmer, A J Capute
Oct 1, 1993·Journal of Intellectual Disability Research : JIDR·K A Day
Sep 1, 1993·Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists·L E Arnold
Jan 1, 1996·Psychopharmacology·M SanfilipoJ Rotrosen
Jan 1, 1997·Journal of Child and Adolescent Psychopharmacology·J N Giedd, K G Smith
Jan 1, 1997·Journal of Child and Adolescent Psychopharmacology·N N SinghH Wechsler
Apr 1, 1990·Journal of Child and Adolescent Psychopharmacology·R D HuntP O'Connell
Jan 1, 1991·Journal of Child and Adolescent Psychopharmacology·L E Arnold, M G Aman
Jan 1, 1995·Journal of Psychopharmacology·P WillnerP Brain

❮ Previous
Next ❯

Citations

Dec 1, 2006·Journal of Occupational Rehabilitation·Harry KarlinskyYassaman Bayani
Mar 19, 2002·Journal of Intellectual Disability Research : JIDR·C Gustafsson, K Sonnander
Oct 9, 2003·Journal of Clinical Microbiology·Robyn A WallacePenelope M Webb
Jun 6, 2009·Intellectual and Developmental Disabilities·Kathleen HumphriesTom Seekins
Oct 30, 2014·American Journal on Intellectual and Developmental Disabilities·Haleigh M Scott, Susan M Havercamp
Jan 30, 2016·Intellectual and Developmental Disabilities·Haleigh M Scott, Susan M Havercamp
Sep 13, 2015·Progress in Neuro-psychopharmacology & Biological Psychiatry·Giuliana Galli CarminatiFederico Carminati
Sep 11, 2004·Journal of Intellectual Disability Research : JIDR·R A WallaceP M Webb
Aug 10, 2013·Pharmacoepidemiology and Drug Safety·Tan DoanNicholas Lennox
Nov 16, 2004·Research in Developmental Disabilities·Børge Holden, Jens Petter Gitlesen
Nov 16, 2004·Research in Developmental Disabilities·Jane A McGillivray, Marita P McCabe
May 23, 2006·Epilepsy & Behavior : E&B·Willeke van BlarikomAd Th G van Gennep
Jun 17, 2015·Paediatric Drugs·Abraham J ValkenburgDick Tibboel
Aug 21, 2019·Journal of Applied Research in Intellectual Disabilities : JARID·Mario G MazzaMassimo Clerici
Jun 17, 2009·International Journal of Adolescent Medicine and Health·Mohammed MoradJoav Merrick
Jun 24, 2017·Journal of Intellectual Disability Research : JIDR·M O'DwyerM C Henman
Nov 4, 2000·The Medical Journal of Australia·N G LennoxN S Edwards

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
Robert Goldney, Marcus Bain
Pediatric Emergency Care
B A Spirko, J F Wiley
© 2021 Meta ULC. All rights reserved